Nevertheless, multiple daily insulin injections therapy is still used by a significant proportion of people with type 1 diabetes around the world, and once‐weekly basal insulin may represent an opportunity to simplify insulin therapy in individuals without access to (or refusing) technological devices or exhibiting poor treatment adherence, with the additional aim of reducing the frequency of recurrent DKA episodes in the latter, provided that the above‐mentioned concerns on hypoglycaemia risk are resolved. Here, INS is linked to Hypoglycemia.